Johnson & Johnson · BCBA:JNJ.B

Johnson & Johnson financial statements

Johnson & Johnson's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue94.2B88.8B85.2B80.0B78.7B82.6B82.1B81.6B76.5B71.9B
Cost of revenue30.3B27.5B26.6B24.6B23.4B28.4B27.6B27.1B25.4B21.8B
Gross profit63.9B61.4B58.6B55.4B55.3B54.2B54.5B54.5B51.0B50.1B
Research and development109.0M1.84B483.0M0012.2B11.4B10.8B10.6B9.14B
Selling, general and administrative23.7B22.9B21.5B20.2B20.1B22.1B22.2B22.5B21.5B20.1B
Depreciation and amortization7.50B7.34B7.49B6.97B7.39B7.23B7.01B6.93B5.64B3.75B
Interest expense971.0M755.0M772.0M276.0M183.0M201.0M318.0M1.00B934.0M726.0M
Income before tax32.6B16.7B15.1B19.4B19.2B16.5B17.3B18.0B17.7B19.8B
Income tax5.78B2.62B1.74B2.99B1.38B1.78B2.21B2.70B16.4B3.26B
Net income26.8B14.1B35.2B17.9B20.9B14.7B15.1B15.3B1.30B16.5B
Earnings per share, basic11.135.8413.886.837.935.595.725.700.486.04
Earnings per share, diluted11.035.7913.726.737.815.515.635.610.475.93

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents19.7B24.1B21.9B12.9B14.5B14.0B17.3B18.1B17.8B19.0B
Short-term investments393.0M417.0M1.07B9.39B17.1B11.2B1.98B1.58B472.0M22.9B
Receivables17.2B14.8B14.9B14.0B15.3B13.6B14.5B14.1B13.5B11.7B
Inventory14.2B12.4B11.2B10.3B10.4B9.34B9.02B8.60B8.77B8.14B
Current assets55.6B55.9B53.5B55.3B61.0B51.2B45.3B46.0B43.1B65.0B
Property, plant and equipment23.2B20.5B19.9B18.0B19.0B18.8B17.7B17.0B17.0B15.9B
Goodwill48.8B44.2B36.6B36.0B25.4B36.4B33.6B30.5B31.9B22.8B
Total assets199.2B180.1B167.6B187.4B182.0B174.9B157.7B153.0B157.3B141.2B
Accounts payable12.0B10.3B9.63B9.89B11.1B9.51B8.54B7.54B7.31B6.92B
Current liabilities54.1B50.3B46.3B55.8B45.2B42.5B36.0B31.2B30.5B26.3B
Long-term debt39.4B30.7B25.9B26.9B30.0B32.6B26.5B27.7B30.7B22.4B
Total debt49.9B38.4B30.8B41.2B35.9B37.1B27.7B33.1B36.1B28.8B
Total liabilities117.7B108.6B98.8B110.6B108.0B111.6B98.3B93.2B97.1B70.8B
Shareholders' equity81.5B71.5B68.8B76.8B74.0B63.3B59.5B59.8B60.2B70.4B
Shares outstanding2.41B2.41B2.41B2.41B2.41B2.41B2.60B2.63B2.63B2.63B

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations24.5B24.3B22.8B21.2B23.4B23.5B23.4B22.2B21.1B18.8B
Capital spending-4.83B-4.42B-4.54B-4.01B-3.65B-3.35B-3.50B-3.67B-3.28B-3.23B
Free cash flow19.7B19.8B18.2B17.2B19.8B20.2B19.9B18.5B17.8B15.5B
Cash from investing-23.6B-18.6B878.0M-12.4B-8.68B-20.8B-6.19B-3.17B-14.9B-4.76B
Cash from financing-5.54B-3.13B-15.8B-8.87B-14.0B-6.12B-18.0B-18.5B-7.67B-8.55B
Share buybacks-5.95B-2.43B-5.05B-6.04B-3.46B-3.22B-6.75B-5.87B-6.36B-8.98B
Change in cash-4.40B2.25B7.73B-360.0M502.0M-3.32B-802.0M283.0M-1.15B5.24B